The effect of Qiliqiangxin Capsules on cardiac function and prognosis of patients with ST-segment elevation acute myocardial infarction after PCI
LI Ying ZHAO Lihong
Integrated TCM & Western Medicine Department, the Second Policlinic Directly under the Authority of Hebei Province, Hebei Province, Shijiazhuang 050000, China
Abstract：Objective To study the effect of Qiliqiangxin Capsules on cardiac function and prognosis of patients with ST-segment elevation acute myocardial infarction after percutaneous coronary intervention (PCI). Methods From January 2016 to May 2017, 60 patients with ST-segment elevation acute myocardial infarction after PCI in the Second Policlinic Directly under the Authority of Hebei Province were selected and divided into observation group and control group according to treatment, with 30 cases in each group. All patients were treated with conventional western medicine treatment after PCI. In addition to standard therapy, the observation group was treated by Qiliqiangxin Capsules, and the control group were treated by placebo. Before and 6 months after treatment, the matrix metalloproteinase-9 (MMP-9), tumor necrosis factor alpha (TNF-α) and nitric oxide (NO) concentration were compared. And the left ventricular ejection fraction (LVEF), left ventricular end diastolic diameter (LVEDD), left ventricular posterior wall thickness (LVPWD), interventricular septal thickness (IVSd), and cardiac events were also compared. Results After treatment, the levels of MMP-9, TNF-α in the observation group were lower than those in the control group, and the leud of NO was higher than that in the control group, with statistically significant difference (P < 0.05). After treatment, the level of LVEF in the observation group was higher than that in the control group, and the levels of LVEDD, LVPWD, IVSd in the observation group were lower than those in the control group, with statistically significant difference (P < 0.05). The incidence of cardiac events in the control group was lower than that in the control group (P < 0.05). Conclusion Qiliqiangxin Capsules is beneficial to the repair of damaged myocardial cells. Besides, it can improve the ability of myocardium contraction, promote myocardial microcirculation andinhibit ventricular remodeling after myocardial infarction.
李英 赵丽红. 芪苈强心胶囊对ST段抬高型急性心肌梗死PCI术后患者心功能及预后的影响[J]. 中国医药导报, 2018, 15(6): 137-140.
LI Ying ZHAO Lihong. The effect of Qiliqiangxin Capsules on cardiac function and prognosis of patients with ST-segment elevation acute myocardial infarction after PCI. 中国医药导报, 2018, 15(6): 137-140.
[1] Arslanian-Engoren C，Scott LD. Delays in treatment-seeking decisions among women with myocardial infarction [J]. Dimens Crit Care Nurs，2017，36（5）：298-303.
[2] Li X，Li B，Gao J，et al. Influence of angiographic spontaneous coronary reperfusion on long-term prognosis in patients with ST-segment elevation myocardial infarction [J]. Oncotarget，2017，8（45）：79 767-79 774.
[3] Wang H，Zhang X，Yu P，et al. Traditional Chinese medication qiliqiangxin protects against cardiac remodeling and dysfunction in spontaneously hypertensive rats [J]. Int J Med Sci，2017，14（5）：506-514.
[4] 中华医学会心血管病学分会，《中华心血管病杂志》编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志，2015，43（5）：380-393.
[5] 王忠彩，李菲菲.急性心肌梗死患者冠脉PCI术后血清soL-CXCL16及NT-proBNP水平变化分析[J].临床和实验医学杂志，2017，16（12）：1169-1171.
[6] 陈默，吴先军，杨小莉，等.不同治疗方案对急性ST抬高型心肌梗死患者PCI术后心功能及心肌微循环的影响[J].临床和实验医学杂志，2017，16（20）：2030-2033.
[7] Kang SH，Lee CW，Baek S，et al. Impact of left main coronary artery disease on long-term mortality in patients under?鄄going drug-eluting stent implantation [J]. Clin Res Car?鄄diol，2017，106（12）：953-959.
[8] 胡小武，惠杰.骨髓间充质干细胞治疗心肌梗死的研究进展[J].浙江临床医学，2014，16（9）：1500-1502.
[9] 王志军，曹佳佳，刁增利，等.芪苈强心胶囊改善心肌梗死后心力衰竭患者的临床症状[J].中成药，2015，37（1）： 44-48.
[10] 曾吉祥.初发急性ST段抬高型心肌梗死中医证型与相关因素分析[D].北京：北京中医药大学，2016.
[11] 李军，张振鹏，王阶.急性ST段抬高型心肌梗死的中西医结合治疗策略[J].中国中西医结合急救杂志，2015，22（1）：103-104.
[12] 高艳霞，李小虎.芪苈强心胶囊治疗舒张性心力衰竭的临床观察[J].中国现代医生，2016，54（7）：107-109.
[13] 钱玉红，李争，王敏，等.芪苈强心胶囊对阿霉素所致心力衰竭大鼠氧化损伤的影响[J].疑难病杂志，2014，13（6）：625-633.
[14] 王生平，冯胜红，冯永生，等.芪苈强心胶囊佐治缺血性心肌病左心衰竭的临床价值[J].疑难病杂志，2015，14（12）：1284-1287.
[15] 陈要起，穆金兴，陈洪波，等.芪苈强心胶囊对糖尿病心肌病患者预后的影响[J].海南医学，2017，28（7）：1-4.
[16] Liu D，Cui W，Liu B，et al. Atorvastatin protects vascular smooth muscle cells from TGF-β1-stimulated calcification by inducing autophagy via suppression of the β-catenin pathway [J]. Cell Physiol Biochem，2014，33（1）：129-141.
[17] Liu W，Liu Y，Jiang H，et al. Plasma levels of interleukin 18，interleukin 10，and matrix metalloproteinase-9 and -137G/C polymorphism of interleukin 18 are associated with incidence of in-stent restenosis after percutaneous oronary intervention [J]. Inflammation，2013，36（5）：1129-1135.
[18] 孙颖，郝艳丽，李延辉，等.重组脑利钠肽辅助治疗老年心力衰竭患者的疗效及其对心功能、炎性指标的影响[J].疑难病杂志，2017，16（1）：10-13.
[19] 邓远琼，邓远琪，刘伯胜，等.高血压及叶酸、维生素B12干预对脑梗死患者血管内皮功能和血同型半胱氨酸、一氧化氮水平的影响[J].临床神经病学杂志，2013， 26（6）：411-414.
2018, Vol. 15 
京公网安备 11010502046598号